Oncotarget

Vol 9, No 49

June 26, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 49 of Oncotarget features Figure 4, "Effects of BET inhibition and its potentiation by HDAC inhibition are mediated in part by induction of apoptosis by caspase 3/7," by Kim, et al.

Table of Contents

Research Papers

Gene-environment interactions and predictors of breast cancer in family-based multi-ethnic groups

Gene-environment interactions and predictors of breast cancer in family-based multi-ethnic groups

https://doi.org/10.18632/oncotarget.25520

Mildred C. Gonzales, James Grayson, Amanda Lie, Chong Ho Yu,  and Shyang-Yun Pamela K. Shiao
29019-29035
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence

The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence

https://doi.org/10.18632/oncotarget.25528

Shariq S. Khwaja, Chunyu Cai, Shahed N. Badiyan, Xiaowei Wang,  and Jiayi Huang
29036-29046
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Oral inflammation promotes oral squamous cell carcinoma invasion

Oral inflammation promotes oral squamous cell carcinoma invasion

https://doi.org/10.18632/oncotarget.25540

Cameron Goertzen, Hayder Mahdi, Catherine Laliberte, Tomer Meirson, Denise Eymael, Hava Gil-Henn,  and Marco Magalhaes
29047-29063
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A multiomics analysis of S100 protein family in breast cancer

A multiomics analysis of S100 protein family in breast cancer

https://doi.org/10.18632/oncotarget.25561

Patrizia Cancemi, Miriam Buttacavoli, Gianluca Di Cara, Nadia Ninfa Albanese, Serena Bivona, Ida Pucci-Minafra,  and Salvatore Feo
29064-29081
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma

An evaluation in vitro of the efficacy of nutlin-3 and topotecan in combination with 177Lu-DOTATATE for the treatment of neuroblastoma

https://doi.org/10.18632/oncotarget.25607

Mathias Tesson, Richa Vasan, Andreas Hock, Colin Nixon, Colin Rae, Mark Gaze,  and Robert Mairs
29082-29096
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment

InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment

https://doi.org/10.18632/oncotarget.25624

Masaru Koido, Yuri Tani, Satomi Tsukahara, Yuka Okamoto,  and Akihiro Tomida
29097-29111
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Resveratrol prevents p53 aggregation in vitro and in breast cancer cells

Resveratrol prevents p53 aggregation in vitro and in breast cancer cells

https://doi.org/10.18632/oncotarget.25631

Danielly C. Ferraz da Costa, Nathali P.C. Campos, Ronimara A. Santos, Francisca Hildemagna Guedes-da-Silva, Mafalda Maria D.C. Martins-Dinis, Letícia Zanphorlin, Carlos Ramos, Luciana P. Rangel,  and Jerson L. Silva
29112-29122
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes

Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes

https://doi.org/10.18632/oncotarget.25632

Musalula Sinkala, Nicola Mulder,  and Darren Patrick Martin
29123-29139
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

PARP1-Erk synergism in proliferating cells

PARP1-Erk synergism in proliferating cells

https://doi.org/10.18632/oncotarget.25633

Leonid Visochek,  and Malka Cohen-Armon
29140-29145
Abstract  |  PDF  |  HTML  |  Order a Reprint

Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes

Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes

https://doi.org/10.18632/oncotarget.25635

Sunali Y. Mehta, Brianna C. Morten, Jisha Antony, Luke Henderson, Annette Lasham, Hamish Campbell, Heather Cunliffe, Julia A. Horsfield, Roger R. Reddel, Kelly A. Avery-Kiejda, Cristin G. Print,  and Antony W. Braithwaite
29146-29161
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Collaborating genomic, transcriptomic and microbiomic alterations lead to canine extreme intestinal polyposis

Collaborating genomic, transcriptomic and microbiomic alterations lead to canine extreme intestinal polyposis

https://doi.org/10.18632/oncotarget.25646

Jin Wang, Tianfang Wang, Micah A. Bishop, John F. Edwards, Hang Yin, Stephen Dalton, Laura K. Bryan,  and Shaying Zhao
29162-29179
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas

https://doi.org/10.18632/oncotarget.25650

Kinga Németh, Nikolette Szücs, Sándor Czirják, Lilla Reiniger, Borbála Szabó, Gábor Barna, Katalin Karászi, Péter Igaz, Vladimir Zivkovic, Márta Korbonits, Attila Patócs,  and Henriett Butz
29180-29192
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition

BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition

https://doi.org/10.18632/oncotarget.25670

Sa Rang Kim, Julia M. Lewis, Benoit M. Cyrenne, Patrick F. Monico, Fatima N. Mirza, Kacie R. Carlson, Francine M. Foss,  and Michael Girardi
29193-29207
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Circular RNA CpG island hypermethylation-associated silencing in human cancer

Circular RNA CpG island hypermethylation-associated silencing in human cancer

https://doi.org/10.18632/oncotarget.25673

Humberto J. Ferreira, Veronica Davalos, Manuel Castro de Moura, Marta Soler, Montserrat Perez-Salvia, Alberto Bueno-Costa, Fernando Setien, Sebastian Moran, Alberto Villanueva,  and Manel Esteller
29208-29219
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma

Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma

https://doi.org/10.18632/oncotarget.25678

Masakazu Yoshida, Etsuko Yokota, Tetsushi Sakuma, Tomoki Yamatsuji, Nagio Takigawa, Toshikazu Ushijima, Takashi Yamamoto, Takuya Fukazawa,  and Yoshio Naomoto
29220-29232
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical Research Papers

Evaluation of modified carbapenem inactivation method for suspected carbapenemase among Enterobacteriaceae clinical isolates

Evaluation of modified carbapenem inactivation method for suspected carbapenemase among Enterobacteriaceae clinical isolates

https://doi.org/10.18632/oncotarget.25603

Beiwei Yu, Dong Dong, Mingxia Wang, Yan Guo, Dandan Yin,  and Fupin Hu
29233-29237
Abstract  |  PDF  |  HTML  |  Order a Reprint

Reviews

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants

https://doi.org/10.18632/oncotarget.25579

Natalia Cullell, Caty Carrera, Elena Muiño, Nuria Torres, Jerzy Krupinski,  and Israel Fernandez-Cadenas
29238-29258
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy

Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy

https://doi.org/10.18632/oncotarget.25660

Artem Blagodatski, Margarita Yatsunskaya, Valeriia Mikhailova, Vladlena Tiasto, Alexander Kagansky,  and Vladimir L. Katanaev
29259-29274
Abstract  |  PDF  |  HTML  |  Order a Reprint

Case Reports

Papillary thyroid microcarcinoma (Black Ink)

Papillary thyroid microcarcinoma (Black Ink)

https://doi.org/10.18632/oncotarget.25621

Ersilio Trapanese, Carmine De Bartolomeis, Basilio Angrisani,  and Giulio Tarro
29275-29283
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Corrections

Correction: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

Correction: Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

https://doi.org/10.18632/oncotarget.25721

Abhishek D. Garg, Sanne Elsen, Dmitri V. Krysko, Peter Vandenabeele, Peter de Witte,  and Patrizia Agostinis
29284-29284
Correction  |  PDF

Correction: Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies

Correction: Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies

https://doi.org/10.18632/oncotarget.25726

Fuling Ma, Liang Dai, Zhun Wang, Liqun Zhou, Yuanjie Niu,  and Ning Jiang
29285-29285
Correction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC